103 related articles for article (PubMed ID: 38752435)
1. Patient- and system-level factors associated with racial/ethnic disparities in the delivery of guideline-concordant therapy among US patients with gastric cancer.
da Costa WL; Tan MC; Camp ER; Thrift AP
J Surg Oncol; 2024 May; ():. PubMed ID: 38752435
[TBL] [Abstract][Full Text] [Related]
2. Sociodemographic and Facility-Related Disparities in the Delivery of Guideline-Concordant Therapy Among Patients With Esophageal Adenocarcinoma.
da Costa WL; Camp ER; Thrift AP
JCO Oncol Pract; 2022 Jul; 18(7):e1181-e1197. PubMed ID: 35436147
[TBL] [Abstract][Full Text] [Related]
3. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
4. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
[No Abstract] [Full Text] [Related]
5. Health Insurance Coverage and Racial/Ethnic Disparities in US Childhood and Adolescent Cancer Survival.
Wang X; Brown DS; Cao Y; Ekenga CC; Guo S; Johnson KJ
J Pediatr; 2023 Jun; 257():113378. PubMed ID: 36889628
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
[TBL] [Abstract][Full Text] [Related]
7. Underlying Bias in the Treatment of Pancreatic Cancer: Minorities Treated at the Same Facilities are Less Likely to Receive Neoadjuvant Therapy.
Lopez-Verdugo F; Fong ZV; Lillemoe KD; Blaszkowsky LS; Parikh AR; Wo JY; Hong TS; Ferrone CR; Fernandez-Del Castillo C; Qadan M
Ann Surg; 2023 May; 277(5):829-834. PubMed ID: 34954756
[TBL] [Abstract][Full Text] [Related]
8. Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.
Gold HT; Shao H; Oratz R; Yu O; Hammer M; Richardson S; Boudreau D
Am J Clin Oncol; 2020 Feb; 43(2):101-106. PubMed ID: 31850918
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic differences in survival among gastric cancer patients in california.
Klapheke AK; Carvajal-Carmona LG; Cress RD
Cancer Causes Control; 2019 Jul; 30(7):687-696. PubMed ID: 31102083
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in guideline-concordant cancer care and mortality in the United States.
Fang P; He W; Gomez D; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
Adv Radiat Oncol; 2018; 3(3):221-229. PubMed ID: 30202793
[TBL] [Abstract][Full Text] [Related]
11. Insurance-Based Disparities in Guideline-Concordant Thyroid Cancer Care in the Era of De-escalation.
Ginzberg SP; Soegaard Ballester JM; Wirtalla CJ; Pryma DA; Mandel SJ; Kelz RR; Wachtel H
J Surg Res; 2023 Sep; 289():211-219. PubMed ID: 37141704
[TBL] [Abstract][Full Text] [Related]
12. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
14. Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study.
Herbach EL; Curran M; Roberson ML; Carnahan RM; McDowell BD; Wang K; Lizarraga I; Nash SH; Charlton M
Cancer Causes Control; 2024 Mar; ():. PubMed ID: 38546924
[TBL] [Abstract][Full Text] [Related]
15. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
16. Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
Dinicu AI; Dioun S; Wang Y; Huang Y; Wright JD; Tergas AI
Gynecol Oncol; 2024 Feb; 184():214-223. PubMed ID: 38340647
[TBL] [Abstract][Full Text] [Related]
17. Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
Farrow NE; An SJ; Speicher PJ; Harpole DH; D'Amico TA; Klapper JA; Hartwig MG; Tong BC
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):261-271.e1. PubMed ID: 31924363
[TBL] [Abstract][Full Text] [Related]
18. Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma.
da Costa WL; Gu X; Farjah F; Groth SS; Burt BM; Ripley RT; Carrott PW; Massarweh NN
Ann Thorac Surg; 2022 Jan; 113(1):279-285. PubMed ID: 33484675
[TBL] [Abstract][Full Text] [Related]
19. The impact of health insurance coverage on racial/ethnic disparities in US childhood and adolescent cancer stage at diagnosis.
Wang X; Brown DS; Cao Y; Ekenga CC; Guo S; Johnson KJ
Cancer; 2022 Sep; 128(17):3196-3203. PubMed ID: 35788992
[TBL] [Abstract][Full Text] [Related]
20. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
